BDBM274913 4-{[(3R,6R)-1-{[5-fluoro-2-(2H-1,2,3- triazol-2-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]oxy}-1,1- dimethylfuro[3,4-c]pyridin-3(1H)-one::US9556190, Example 4

SMILES C[C@@H]1CC[C@H](CN1C(=O)c1cc(F)ccc1-n1nccn1)Oc1nccc2c1C(=O)OC2(C)C

InChI Key InChIKey=NPUZEKYIQIDXNS-GDBMZVCRSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 274913   

TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM274913(4-{[(3R,6R)-1-{[5-fluoro-2-(2H-1,2,3- triazol-2-yl...)
Affinity DataIC50:  1.00E+4nMAssay Description: In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM274913(4-{[(3R,6R)-1-{[5-fluoro-2-(2H-1,2,3- triazol-2-yl...)
Affinity DataIC50:  23nMAssay Description: In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent